Printer Friendly

SCIMED ANNOUNCES NEW PRODUCT

 SCIMED ANNOUNCES NEW PRODUCT
 MINNEAPOLIS, April 13 /PRNewswire/ -- SCIMED Life Systems, Inc.


(NADAQ-NMS: SMLS) announced today the introduction of the COBRA(TM) 10 coronary balloon angioplasty catheter. The COBRA 10 is an over-the-wire catheter compatible with .010" guide wires and enables SCIMED to compete in a new market segment estimated to be $25 million annually. The COBRA 10 is the smallest over-the-wire device currently available and provides the same important features of the COBRA 14 Q proximal COBRAID(TM) technology for superior push, distal high density Scilene(TM) along with patented taper technology for superior track, and the energy transfer segment which transfers proximal push into distal track.
 SCIMED Life Systems, Inc. develops, manufactures, and markets disposable medical devices, principally coronary angioplasty catheters, for interventional treatment of coronary artery disease. SCIMED's shares are traded on the NASDAQ National Market System under the symbol SMLS.
 -0- 4/13/92
 /Contact: Karen J. Kelsey of SCIMED Life Systems, 612-420-0329/
 (SMLS) CO: SCIMED Life Systems, Inc. ST: Minnesota IN: MTC SU: PDT


AL -- MN009 -- 7660 04/13/92 10:37 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 13, 1992
Words:178
Previous Article:NEW CREF GLOBAL EQUITIES ACCOUNT EXPANDS DIVERSIFICATION OF TIAA-CREF RETIREMENT SYSTEM
Next Article:STERLING SOFTWARE REGISTERS WITH SEC TO OFFER 2 MILLION SHARES OF COMMON STOCK


Related Articles
SCIMED ANNOUNCES NEW PRODUCT
SCIMED ANNOUNCES FOURTH QUARTER AND FISCAL 1992 RESULTS
SCIMED TO CONSTRUCT NEW FACILITY
SCIMED RECEIVES FDA APPROVAL FOR TWO NEW PTCA ANGIOPLASTY PRODUCTS
SCIMED ANNOUNCES INTRODUCTION OF HIGH-PERFORMANCE, NON-COMPLIANT PTCA BALLOON CATHETER AND ITS FIRST CORONARY GUIDE WIRE
SCIMED COMPLETES PURCHASE OF BELGIAN MANUFACTURING FACILITY
SCIMED TO DISPLAY PRODUCTS AT AMERICAN HEART ASSOCIATION'S 66TH SCIENTIFIC SESSIONS
SCIMED RECEIVES FDA APPROVAL TO MARKET DISPATCH CORONARY INFUSION CATHETER
DAN COLE IS PROMOTED TO PRESIDENT OF SCIMED; DALE SPENCER ASSUMES ROLE OF CHAIRMAN OF THE BOARD
SCIMED DISPLAYS FIVE NEW DEVICES AT

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters